OtherLetters to the Editor
Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma
Romain-David Seban, Laurence Champion, Izza Muneer, Shwe Synn, Lawrence H. Schwartz and Laurent Dercle
Journal of Nuclear Medicine May 2021, jnumed.121.262361; DOI: https://doi.org/10.2967/jnumed.121.262361
Romain-David Seban
1 Institut Curie;
Laurence Champion
1 Institut Curie;
Izza Muneer
2 Department of Internal Medicine, Montefiore/Albert Einstein College of Medicine, Bronx, NY;
Shwe Synn
2 Department of Internal Medicine, Montefiore/Albert Einstein College of Medicine, Bronx, NY;
Lawrence H. Schwartz
3 Department of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, New York;
Laurent Dercle
4 Department of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, United States


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 64, Issue 12
December 1, 2023
Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma
Romain-David Seban, Laurence Champion, Izza Muneer, Shwe Synn, Lawrence H. Schwartz, Laurent Dercle
Journal of Nuclear Medicine May 2021, jnumed.121.262361; DOI: 10.2967/jnumed.121.262361
Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma
Romain-David Seban, Laurence Champion, Izza Muneer, Shwe Synn, Lawrence H. Schwartz, Laurent Dercle
Journal of Nuclear Medicine May 2021, jnumed.121.262361; DOI: 10.2967/jnumed.121.262361
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.